Equities

Shanghai MicroPort MedBot Group Co Ltd

Shanghai MicroPort MedBot Group Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (HKD)15.10
  • Today's Change-0.04 / -0.26%
  • Shares traded322.50k
  • 1 Year change-19.68%
  • Beta--
Data delayed at least 15 minutes, as of May 22 2024 09:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Shanghai MicroPort Medical Robot Group Co Ltd is a company engaged in the development of surgical instruments. The Company's main business is the design, development and commercialization of innovative surgical robots. The Company's products include Toumai Laparoscopic Surgical Robot, DFVision 3D Electronic Laparoscope and Honghu Orthopedic Surgical Robot. The Company's surgical robots are used in multiple minimally invasive surgery fields, including endoscopic surgery, orthopedic surgery, pan-vascular surgery, natural cavity surgery and percutaneous puncture surgery. In addition, the Company also provides education and training services for its surgical robot MedBot.

  • Revenue in HKD (TTM)112.74m
  • Net income in HKD-1.09bn
  • Incorporated2015
  • Employees650.00
  • Location
    Shanghai MicroPort MedBot Group Co LtdRoom 101, Area B, Building 1601 Zhangdong Road, China (Shanghai)Pilot Free Trade ZoneSHANGHAI 201203ChinaCHN
  • Phone+86 2 138954600
  • Websitehttps://www.medbotsurgical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Ship Healthcare Holdings Inc31.53bn689.12m12.23bn8.05k16.891.6319.350.3878142.55142.556,363.891,478.711.6421.164.87--3.573.637.146.8610.4010.522.182.291.29--0.289431.2510.267.2814.314.183.095.15
MicroPort Scientific Corp7.41bn-3.72bn12.24bn8.23k--2.07--1.65-2.04-2.044.063.220.23991.095.32900,855.30-16.38-11.85-27.68-18.0455.9762.96-68.28-44.431.26-4.210.5477--13.077.27-9.42--19.44--
Shanghai Microport EP MedTech Co Ltd394.89m20.69m12.53bn577.00605.846.87--31.740.04080.04080.77823.590.20131.189.01634,687.401.05--1.11--61.35--5.24--12.39--0.014--26.46--85.17------
Micro-Tech Nanjing Co Ltd2.68bn569.23m14.37bn2.40k25.213.57--5.372.812.8113.2319.860.59481.626.911,032,216.0012.9110.7414.9812.8264.8163.0421.7119.375.19--0.0135.4321.7821.2046.9920.3239.33--
Shanghai MicroPort MedBot Group Co Ltd112.74m-1.09bn14.51bn650.00--25.92--128.73-1.14-1.140.11760.58420.06230.374642.10173,453.30-60.96---86.19--14.05---978.59--0.8238-11.040.5427--384.16--11.20------
Shenzhen YHLO Biotech Co Ltd1.97bn366.41m14.92bn1.76k40.885.27--7.590.59560.59563.214.620.47981.114.911,037,196.007.0316.439.1224.1662.1453.2614.6620.011.50--0.187230.28-48.4223.02-64.9356.3228.88--
Shanghai Haohai Biological Technology2.84bn448.56m15.01bn2.16k16.191.1722.825.292.632.6316.6636.450.37651.557.501,316,169.005.894.846.865.5070.3472.0915.6516.504.50--0.063536.8625.2711.26130.580.076211.9614.27
Shanghai MicroPort Edvcl MdTch Grp CoLtd1.36bn595.09m15.59bn908.0023.913.58--11.484.914.9111.2732.800.37691.607.961,387,329.0016.3517.6818.1219.4375.6176.6043.3942.259.49--0.00844.4632.4338.7237.9840.2850.18--
Poly Medicure Ltd.1.29bn242.07m15.69bn2.34k64.8811.3951.9612.1726.8926.89143.25153.180.80082.255.44--15.0313.1618.5016.1264.9258.1118.7716.691.7733.540.105915.1023.3617.6344.0531.6128.858.45
Top Glove Corporation Bhd3.41bn-1.17bn16.25bn10.00k--1.65--4.76-0.0876-0.08760.2560.72340.2811--8.11128,154.80-9.0524.37-10.3931.04--43.76-32.2025.881.49-61.540.087470.79-59.49-11.77-510.18---4.47--
Beijing Balance Medical Technolgy Co Ltd411.92m120.58m16.33bn473.00136.5912.54--39.630.81150.81152.778.840.30611.065.72807,636.208.168.068.488.4089.4089.4126.6730.029.77--0.009469.1925.5727.3521.0928.10125.94--
Data as of May 22 2024. Currency figures normalised to Shanghai MicroPort MedBot Group Co Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

2.99%Per cent of shares held by top holders
HolderShares% Held
Global X Management Co. LLCas of 09 May 202411.91m1.25%
The Vanguard Group, Inc.as of 09 May 20248.92m0.94%
HuaAn Fund Management Co., Ltd.as of 31 Dec 20233.34m0.35%
BetaShares Capital Ltd.as of 30 Apr 2024744.15k0.08%
China Asset Management Co., Ltd.as of 30 Jun 2023692.50k0.07%
ALPS Advisors, Inc.as of 10 May 2024676.00k0.07%
CSOP Asset Management Ltd.as of 09 May 2024635.85k0.07%
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 30 Jun 2023634.50k0.07%
BlackRock Advisors (UK) Ltd.as of 09 May 2024505.00k0.05%
E Fund Asset Management Co. Ltd.as of 30 Jun 2023437.00k0.05%
More ▼
Data from 30 Jun 2023 - 16 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.